- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-TAF12
TAF12 Polyclonal Antibody for WB, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
WB, IHC, IP, ChIP, ELISA
Conjugaison
Non conjugué
N° de cat : 12353-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules Y79 |
Résultats positifs en IP | cellules Y79 |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 8 publications below |
IHC | See 1 publications below |
ChIP | See 1 publications below |
Informations sur le produit
12353-1-AP cible TAF12 dans les applications de WB, IHC, IP, ChIP, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | TAF12 Protéine recombinante Ag3017 |
Nom complet | TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa |
Masse moléculaire calculée | 18 kDa |
Poids moléculaire observé | 21 kDa |
Numéro d’acquisition GenBank | BC011986 |
Symbole du gène | TAF12 |
Identification du gène (NCBI) | 6883 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
TAF12, also named TAF15 or TAF2J, is a TBP-associated factor that is contained in Pol I- and Pol II-specific TBP-TAF complexes, it is also a component of the transcription factor IID (TFIID) complex, which is essential for mediating regulation of RNA polymerase transcription. TAF12 plays a key role in regulating eukaryotic gene expression by directly binding promoters and enhancer-bound transactivator proteins. Likewise, TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation. Observed MW of TAF12 is from 14-17 kDa and 17-21 kDa.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for TAF12 antibody 12353-1-AP | Download protocol |
IP protocol for TAF12 antibody 12353-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Cancer Cell A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia.
| ||
Cell Metab Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease. | ||
J Bone Miner Res Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease. | ||
J Bone Miner Res TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation. | ||
J Bone Miner Res Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. | ||
Mol Cell Biol The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. |